| Ytd | 151.83% | |
| 1y | 303.10% |
| Open | 47.20 | Prev Close | 47.07 | Low | 46.26 | High | 47.69 | Mkt Cap | 2.45B |
| Vol | 168.67K | Avg Vol | 1.02M | EPS | 0.84 | P/E | 56.49 | Forward P/E | 34.46 |
| Beta | 2.39 | Short Ratio | 6.31 | Inst. Own | 101.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-28 | 50-d Avg | 31.30 | 200-d Avg | 21.90 | 1yr Est | 52.33 |
CDNA News
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagno
Dow Jones index gained 600 points, CNH Industrial rose 16% after reporting better-than-expected Q2 r
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagno
CareDx is helping to improve outcomes for transplant patients. The health monitor's non-invasive tes
Gainers Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular sessio
HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral and mainta
CareDx, Inc. (CDNA) Q2 2026 Earnings Call Transcript
CareDx (CDNA) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estim
CareDx NASDAQ: CDNA reported second-quarter 2026 revenue growth of 52% as the transplant diagnostics
Gainers Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's
CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.37 per share which beat the analyst consensus
CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $447.000 million-$465.000 million to $490.000
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagno
CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings
Amova Asset Management Americas Inc. raised its holdings in shares of CareDx, Inc. (NASDAQ: CDNA) by
CareDx has a transplant-testing franchise that taps into recurring surveillance demand and has deepe
CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The late
CareDx ($CDNA) shares surge 28% as Medicare finalizes continued coverage for its kidney, heart, and
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's
U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, sto
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnostics company in transplant, special
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagno
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnos
CDNA closes its Naveris buyout, adding NavDx and expanding its precision diagnostics reach into high
CareDx has transformed into a focused, high-acuity specialty diagnostics platform, emphasizing repea
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnos
CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading
The CEO sold 17,683 shares for a transaction value of approximately ~$425,000 at a weighted average
CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading
CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused o
CareDx, Inc.Common StockPreferred StockDebt SecuritiesWarrantsSubscription RightsUnitsWe may offer
CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused o
CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $420.000 million-$444.000 million to $447.000
CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.34 per share which beat the analyst consensus
CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused o
CareDx Inc. (CDNA) sells Lab Products business to EuroBio Scientific for $170 million in cash, focus
U.S. stocks were mixed on Thursday, with the Dow Jones gaining 0.1%. Aehr Test Systems shares rose 1
CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused
Wells Fargo analyst Brandon Couillard maintains CareDx (NASDAQ:CDNA) with a Equal-Weight and rais
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.12 per share which missed the analyst consens